MAPT (Tau) Expression Is a Biomarker for an Increased Rate of Survival for Low‑grade Glioma

Oncology Reports - Greece
doi 10.3892/or.2018.6896
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

MAPT (Tau) Expression Is a Biomarker for an Increased Rate of Survival in Pediatric Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2018English

Radiotherapy for Low-Grade Glioma(Probably Benign-Glioma)

Japanese Journal of Neurosurgery
SurgeryNeurology
1998English

Defining an Intermediate-Risk Group for Low-Grade Glioma: A National Cancer Database Analysis

Anticancer Research
MedicineCancer ResearchOncology
2019English

Phase II Trial of Conformal Radiation Therapy for Pediatric Low-Grade Glioma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

PROX1 Is a Predictor of Survival for Gliomas WHO Grade II

British Journal of Cancer
Cancer ResearchOncology
2011English

AKT2 Expression Is Associated With Glioma Malignant Progression and Required for Cell Survival and Invasion

Oncology Reports
MedicineCancer ResearchOncology
2010English

Circulating Biomarkers for High-Grade Glioma

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Association of Carcinoid Tumor and Low Grade Glioma

World Journal of Surgical Oncology
SurgeryOncology
2012English

Quantitative Fluorescence Using 5-Aminolevulinic Acid-Induced Protoporphyrin IX Biomarker as a Surgical Adjunct in Low-Grade Glioma Surgery

Journal of Neurosurgery
SurgeryNeurology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy